Occult metastases of oral maxillary squamous cell carcinoma: Systematic review and meta-analysis

Head Neck. 2023 Mar;45(3):733-744. doi: 10.1002/hed.27276. Epub 2022 Dec 14.

Abstract

Squamous cell carcinoma (SCC) is the most common malignant neoplasm of the oral cavity. The performance of END (elective neck dissection) in cases of maxillary SCC is controversial because the literature traditionally classified maxillary tumors as having low metastatic potential. The aim of this systematic review and meta-analysis was to determine the percentage of occult cervical metastases in maxillary SCC to identify in which cases there is the need to perform an END. We searched the PubMed database to select articles dated from 2000 to 2020 that fulfilled our inclusion criteria; finally, we reviewed 27 manuscripts. We show that the overall cervical and occult metastases rate was 35% and 19%, respectively. For T1, the percentage of occult metastasis rate was 11%; for T2, it was 16%; for T3, it was 20%; and for T4, it was 32%. We suggest END (levels I-II-III) as treatment to T3/T4 cN0 patients.

Keywords: cervical metastases; elective neck dissection; maxillary gingiva; occult metastases; squamous cell carcinoma.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms* / pathology
  • Humans
  • Lymphatic Metastasis
  • Mouth Neoplasms* / pathology
  • Mouth Neoplasms* / therapy
  • Neck Dissection
  • Neoplasm Staging
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck / pathology